Company intelligence / Profile preview

The Motley Fool

Alexandria*, Virginia, USAfool.com ↗

Ownership: Private
Employees: ~360
Development stage: Commercial

Overview

The Motley Fool provides financial education and investment advice to individual investors through newsletters, podcasts, books, and managed investment products. It does not conduct life science or healthcare R&D or clinical trials[1][2][3].

Industry: Investors

Drug pipeline

3 assets

biktarvy

Commercial

Indications: HIV

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on The Motley Fool.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Motley Fool.

Explore the full profile